Published in Am J Obstet Gynecol on November 22, 2012
"Pelvic: deferred"-have nongynecologists been right all along? Am J Obstet Gynecol (2013) 0.75
Obstetrician-gynecologists' beliefs about performing less cervical cancer screening: the pendulum swings. Am J Obstet Gynecol (2015) 0.75
Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA (2000) 10.91
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med (2004) 6.33
PSA screening among elderly men with limited life expectancies. JAMA (2006) 5.70
ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol (2009) 4.27
Physicians' perceptions, preparedness for reporting, and experiences related to impaired and incompetent colleagues. JAMA (2010) 3.98
Physician attitudes toward regionalization of adult critical care: a national survey. Crit Care Med (2009) 1.79
The pelvic examination as a screening tool: practices of US physicians. Arch Intern Med (2011) 1.72
Patient-centered care and preference-sensitive decision making. JAMA (2009) 1.44
Physicians' beliefs about conscience in medicine: a national survey. Acad Med (2009) 1.26
Screening for ovarian cancer: recommendation statement. Ann Fam Med (2004) 1.24
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01
Committee opinion No. 534: well-woman visit. Obstet Gynecol (2012) 1.00
Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health (Larchmt) (2010) 0.99
Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect (2001) 0.98
Distress and pain during pelvic examinations: effect of sexual violence. Obstet Gynecol (2008) 0.91
Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med (2012) 0.88
Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women. Am J Obstet Gynecol (2008) 0.86
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA (2005) 4.32
Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med (2004) 3.93
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Burden of cervical cancer in the United States, 1998-2003. Cancer (2008) 2.57
Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers. Obstet Gynecol (2011) 2.35
Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol (2008) 2.21
Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
Young women's perceptions of the benefits of childbearing: associations with contraceptive use and pregnancy. Perspect Sex Reprod Health (2013) 2.12
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry. J Am Dent Assoc (2011) 2.10
The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception (2008) 2.09
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
Safety of mifepristone abortions in clinical use. Contraception (2005) 2.04
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer (2008) 2.00
H1N1 influenza in pregnancy: cause for concern. Obstet Gynecol (2009) 1.85
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
The pelvic examination as a screening tool: practices of US physicians. Arch Intern Med (2011) 1.72
Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol (2011) 1.70
Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med (2008) 1.70
USPSTF recommendations for STI screening. Am Fam Physician (2008) 1.68
Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev (2006) 1.65
HPV vaccination--more answers, more questions. N Engl J Med (2007) 1.64
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause (2009) 1.63
Reducing ultraviolet radiation exposure among outdoor workers: state of the evidence and recommendations. Environ Health (2007) 1.63
Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen. Urology (2009) 1.62
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine (2012) 1.61
Preventing excessive weight gain in pregnancy: how do prenatal care providers approach counseling? J Womens Health (Larchmt) (2010) 1.56
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol (2011) 1.51
Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health. Prev Chronic Dis (2008) 1.49
The cost-effectiveness of male HPV vaccination in the United States. Vaccine (2011) 1.48
Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health (Larchmt) (2007) 1.45
Evidence-based medicine versus liquid-based cytology. Obstet Gynecol (2008) 1.43
Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol (2006) 1.43
Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep (2002) 1.40
Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer (2011) 1.36
One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Obstet Gynecol (2011) 1.36
Cost-effectiveness of human papillomavirus vaccination in the United States. Emerg Infect Dis (2008) 1.35
A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005. J Womens Health (Larchmt) (2006) 1.34
Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev (2011) 1.33
State indoor tanning laws and adolescent indoor tanning. Am J Public Health (2014) 1.30
Human Papillomavirus-Associated Cancers - United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2016) 1.29
Persistent hot flushes in older postmenopausal women. Arch Intern Med (2008) 1.28
Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004. Cancer (2008) 1.26
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause (2009) 1.23
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev Med (2013) 1.22
Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol (2011) 1.22
Cervical cancer screening among young adult women in the United States. Cancer Epidemiol Biomarkers Prev (2013) 1.22
Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012. MMWR Morb Mortal Wkly Rep (2014) 1.21
Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine (2013) 1.20
Chapter 25: Education, training, and communication for HPV vaccines. Vaccine (2006) 1.19
Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol (2005) 1.18
Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med (2013) 1.17
Do racial and ethnic differences in contraceptive attitudes and knowledge explain disparities in method use? Perspect Sex Reprod Health (2012) 1.14
Sex-selective abortion in Nepal: a qualitative study of health workers' perspectives. Womens Health Issues (2011) 1.14
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol (2007) 1.13
Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis (2008) 1.13
Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer (2008) 1.12
Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer (2011) 1.12
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer (2008) 1.11
Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat (2012) 1.10
Contraceptive decision-making in sexual relationships: young men's experiences, attitudes and values. Cult Health Sex (2010) 1.10
Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2007) 1.10
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04. Adv Data (2006) 1.08
Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol (2003) 1.07
Discontinuation of postmenopausal hormone therapy. Am J Med (2005) 1.05
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep (2014) 1.05
Update of HPV-associated female genital cancers in the United States, 1999-2004. J Womens Health (Larchmt) (2009) 1.05
Factors influencing the provision of long-acting reversible contraception in California. Obstet Gynecol (2014) 1.05
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2005) 1.04
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Why the Pap test? Awareness and use of the Pap test among women in the United States. J Womens Health (Larchmt) (2011) 1.03
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003. Cancer (2008) 1.03
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer (2008) 1.02
Attitudes toward the vaginal ring and transdermal patch among adolescents and young women. J Adolesc Health (2009) 1.01
Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. J Low Genit Tract Dis (2008) 1.01
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01
Cervical carcinoma rates among young females in the United States. Obstet Gynecol (2012) 1.00
Knowledge of emergency contraception among women aged 18 to 44 in California. Am J Obstet Gynecol (2004) 0.99
Indoor tanning device use among male high school students in the United States. J Adolesc Health (2011) 0.97
Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol (2009) 0.97